Please login to the form below

Not currently logged in
Email:
Password:

eye disease

This page shows the latest eye disease news and features for those working in and with pharma, biotech and healthcare.

Novartis gets EU nod for Luxturna gene therapy

Novartis gets EU nod for Luxturna gene therapy

Novartis has secured EMA approval Luxturna, a gene therapy for a rare eye disease, almost a year after it was given the green light in the US. ... That works out at around $375, 000 per vial, which is enough to treat one eye, around $50, 000 less than

Latest news

More from news
Approximately 6 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Pharma deals during March 2013 Pharma deals during March 2013

    However, ophthalmology is increasingly an area of interest in the industry with potential for growth as the global population ages; it is estimated that around 25m people have dry eye disease ... 175. SARcode Bioscience/ Shire. Acquisition. SAR 1118 for

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    There is a growing demand for eye care, owing to the rising prevalence of eye disease, an ageing global population and increased demand for healthcare in emerging markets. ... This is demonstrated by the fact that rare disease research is central to its

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • emotive adds to medical team with new Scientific Lead and Associate Medical Writer

    Kate is experienced in a wide range of therapy areas, including immunology, specifically Crohn’s disease, ulcerative colitis and psoriatic arthritis, in ophthalmology, including retinal diseases, glaucoma and dry eye disease, ... emotive is an

  • The power of observation in gathering patient insights

    For example, we recently conducted a multi-country research project for a rare eye disease. ... Patients walked us around their homes; sharing with us stories about life before and after their disease, adding significant layers of insight to the findings

  • PAN trio run for charity

    RP is an inherited disease of the eye, where the light sensitive cells of the retina cease to function and die away. ... However, the research being undertaken at Moorfields Eye Hospital hopes to slow or even reverse this disease by injecting cells from

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics